Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children

Canadian Journal of Ophthalmology

Volumn 50, Issue 3, 2015, Pages 236-241

  Lei, Shaobo ^a   Lam, Wai Ching ^b,c  

^a Program in Neurosciences and Mental Health   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; APRACLONIDINE; BEVACIZUMAB; BRIMONIDINE; DEXAMETHASONE; DORZOLAMIDE PLUS TIMOLOL; KETOROLAC; METHOTREXATE; NEPAFENAC; RANIBIZUMAB; TRIAMCINOLONE; DRUG IMPLANT; GLUCOCORTICOID;

ADOLESCENT; ARTICLE; CAPSULE OPACIFICATION; CASE REPORT; CENTRAL RETINAL THICKNESS; CHILD; CLINICAL EVALUATION; DRUG EFFICACY; DRUG SAFETY; EXUDATIVE RETINITIS; FEMALE; FOLLOW UP; HUMAN; INJECTABLE IMPLANT; INTRAOCULAR PRESSURE; LASER COAGULATION; LENS; MACULAR EDEMA; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; PRESCHOOL CHILD; RELAPSE; RETINA MACULA CYSTOID EDEMA; RETINAL TELANGIECTASIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SUBCAPSULAR CATARACT; TREATMENT OUTCOME; TREATMENT RESPONSE; UVEITIS; VISUAL ACUITY; COMPLICATION; DRUG EFFECTS; DRUG IMPLANT; OFF LABEL DRUG USE; PHYSIOLOGY; RECURRENT DISEASE; VITREOUS BODY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; OFF-LABEL USE; RECURRENCE; RETINAL TELANGIECTASIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITREOUS BODY;

EID: 84930160239     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/j.jcjo.2015.01.007     Document Type: Article

References (28)

1. R. Jain, P. Ferrante, G.T. Reddy, and S. Lightman Clinical features and visual outcome of intermediate uveitis in children Clin Experiment Ophthalmol 33 2005 22 25
2. C. Kirwan, and M. O'Keeffe Cystoid macular oedema in paediatric aphakia and pseudophakia Br J Ophthalmol 90 2006 37 39
3. J.A. Shields, C.L. Shields, S.G. Honavar, and H. Demirci Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture Am J Ophthalmol 131 2001 561 571
4. H. Al-Dhibi, and A.O. Khan Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema J AAPOS 13 2009 400 402
5. A. Prasad, C.C. Patel, and J.E. Puklin Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child Retin Cases Brief Rep 3 2009 125 127
6. A. Sallam, R.M. Comer, and J.H. Chang Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children Arch Ophthalmol 126 2008 200 205
7. N.J. London, A. Chiang, and J.A. Haller The dexamethasone drug delivery system: indications and evidence Adv Ther 28 2011 351 366
8. D.S. Boyer, Y.H. Yoon, and R. Belfort Jr Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema Ophthalmology 121 2014 1904 1914
9. J.A. Haller, F. Bandello, and R. Belfort Jr Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146.e3
10. B.D. Kuppermann, M.S. Blumenkranz, and J.A. Haller Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch Ophthalmol 125 2007 309 317
11. C. Lowder, R. Belfort, and S. Lightman Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis Arch Ophthalmol 129 2011 545 553
12. A. Chan, L.S. Leung, and M.S. Blumenkranz Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion Clin Ophthalmol 5 2011 1043 1049
13. S. Bourgault, M. Aroichane, L.A. Wittenberg, A. Lavallée, and P.E. Ma Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report J Ophthalmic Inflamm Infect 3 2013 1 5
14. N. Kumari, S. Parchand, S. Kaushik, and R. Singh Intractable glaucoma necessitating dexamethasone implant (Ozurdex) removal and glaucoma surgery in a child with uveitis BMJ Case Rep. 2013 Dec 5 2013
15. S. Martínez-Castillo, R. Gallego-Pinazo, R. Dolz-Marco, C. Marín-Lambíes, and M. Díaz-Llopis Adult Coats' disease successfully managed with the dexamethasone intravitreal implant (ozurdex) combined with retinal photocoagulation Case Rep Ophthalmol 3 2012 123 127
16. S.R. Taylor, O. Tomkins-Netzer, L. Joshi, J. Morarji, E. McLoone, and S. Lightman Dexamethasone implant in pediatric uveitis Ophthalmology 119 2012 2412 2412.e2
17. J.A. Haller, F. Bandello, and R. Belfort Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results Ophthalmology 118 2011 2453 2460
18. C. Lowder, R. Belfort Jr, and S. Lightman Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis Arch Ophthalmol 129 2011 545
19. S. Androudi, E. Letko, M. Meniconi, T. Papadaki, M. Ahmed, and C.S. Foster Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema Ocul Immunol Inflamm 13 2005 205 212
20. F. Bandello, L. Berchicci, C. La Spina, and P. Iacono Evidence for anti-VEGF treatment of diabetic macular edema Ophthalmic Res 48 Suppl. 1 2012 16 20
21. R. Fracs, and P. Fracs Intravitreal triamcinolone and elevated intraocular pressure Aust N Z J Ophthalmol 27 1999 431 432
22. J. Jonas, I. Kreissig, and R. Degenring Intraocular pressure after intravitreal injection of triamcinolone acetonide Br J Ophthalmol 87 2003 24 27
23. J.B. Jonas, R.F. Degenring, I. Kreissig, I. Akkoyun, and B.A. Kamppeter Intraocular pressure elevation after intravitreal triamcinolone acetonide injection Ophthalmology 112 2005 593 598
24. D.S. Lam, D.S. Fan, J.S. Ng, C.B. Yu, C.Y. Wong, and A.Y. Cheung Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial Clin Experiment Ophthalmol 33 2005 252 258
25. J. Zarranz-Ventura, E. Carreño, and R.L. Johnston Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency Am J Ophthalmol 158 2014 1136 1145.e5
26. C.C. Patel, N. Mandava, S.C. Oliver, R. Braverman, H. Quiroz-Mercado, and J.L. Olson Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert) Retina 32 2012 537 542
27. I.S. Othman, M. Moussa, and M. Bouhaimed Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications Br J Ophthalmol 94 2010 606 610
28. P.M. Beer, S.J. Bakri, R.J. Singh, W. Liu, G.B. Peters III, and M. Miller Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 2003 681 686